244 related articles for article (PubMed ID: 7992018)
21. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
[TBL] [Abstract][Full Text] [Related]
22. HBeAg/anti-HBe antigenic system in liver diseases in Greece.
Theodoropoulos G; Nakopoulou L; Fertakis A; Papaevangelou G; Hadzis G; Kasfiki A
Hepatogastroenterology; 1983 Dec; 30(6):243-5. PubMed ID: 6327477
[TBL] [Abstract][Full Text] [Related]
23. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).
Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K
J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378
[TBL] [Abstract][Full Text] [Related]
24. Changes in serological markers of hepatitis B virus after renal transplantation.
Urbini Dos Santos C; Sevá-Pereira T; Alves-Filho G; Lorena SL; Soares EC; Mazzali M
Transplant Proc; 2008 Apr; 40(3):749-51. PubMed ID: 18455006
[TBL] [Abstract][Full Text] [Related]
25. Durability of serologic response after lamivudine treatment of chronic hepatitis B.
Dienstag JL; Cianciara J; Karayalcin S; Kowdley KV; Willems B; Plisek S; Woessner M; Gardner S; Schiff E
Hepatology; 2003 Apr; 37(4):748-55. PubMed ID: 12668966
[TBL] [Abstract][Full Text] [Related]
26. IgG subclasses in circulating immune complexes with hepatitis B e antigen in chronic hepatitis B.
Sällberg M; Norder H; Lindh G; Magnius LO
Clin Exp Immunol; 1991 Apr; 84(1):116-21. PubMed ID: 2015701
[TBL] [Abstract][Full Text] [Related]
27. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
[TBL] [Abstract][Full Text] [Related]
28. Spontaneous loss of HBeAg and development of anti-HBe during long-term follow-up of blood donors found to be HBsAg-positive.
Brown SD; Barbara AJ; Lambert T; Wilson DV
Br J Biomed Sci; 1995 Jun; 52(2):106-9. PubMed ID: 8520247
[TBL] [Abstract][Full Text] [Related]
29. [Basic factors affecting the development of chronic hepatitis B virus infection].
Jezek P; Chalupa P
Cas Lek Cesk; 1991 Feb; 130(8):227-30. PubMed ID: 2025893
[TBL] [Abstract][Full Text] [Related]
30. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.
Tsai SL; Chen PJ; Lai MY; Yang PM; Sung JL; Huang JH; Hwang LH; Chang TH; Chen DS
J Clin Invest; 1992 Jan; 89(1):87-96. PubMed ID: 1729285
[TBL] [Abstract][Full Text] [Related]
31. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy.
Leung NW; Lai CL; Chang TT; Guan R; Lee CM; Ng KY; Lim SG; Wu PC; Dent JC; Edmundson S; Condreay LD; Chien RN;
Hepatology; 2001 Jun; 33(6):1527-32. PubMed ID: 11391543
[TBL] [Abstract][Full Text] [Related]
32. Precore wild-type DNA and immune complexes persist in chronic hepatitis B after seroconversion: no association between genome conversion and seroconversion.
Maruyama T; Kuwata S; Koike K; Iino S; Yasuda K; Yotsuyanagi H; Moriya K; Maekawa H; Yamada H; Shibata Y; Milich DR
Hepatology; 1998 Jan; 27(1):245-53. PubMed ID: 9425944
[TBL] [Abstract][Full Text] [Related]
33. [e/Anti-e system in liver disease].
Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O
Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125
[TBL] [Abstract][Full Text] [Related]
34. A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients.
Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Kao JH; Chen DS
Liver Int; 2008 Aug; 28(7):1034-41. PubMed ID: 18492018
[TBL] [Abstract][Full Text] [Related]
35. [Spontaneous seroconversion of HBeAg into anti-HBe in patients with chronic hepatitis B].
Hadzić N; Vucelić B; Dubravcić D; Juricić M; Stavljenić A
Lijec Vjesn; 1988; 110(6-7):181-4. PubMed ID: 3185086
[No Abstract] [Full Text] [Related]
36. Chronic HBV infection. Immunomodulation with levamisole in viremic HBeAg positive or anti-HBe positive patients--a pilot study.
Krastev Z; Jelev D; Antonov K; Alagozian V; Kotzev I
Hepatogastroenterology; 1999; 46(30):3184-8. PubMed ID: 10626183
[TBL] [Abstract][Full Text] [Related]
37. Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B.
Loriot MA; Marcellin P; Bismuth E; Martinot-Peignoux M; Boyer N; Degott C; Erlinger S; Benhamou JP
Hepatology; 1992 Jan; 15(1):32-6. PubMed ID: 1727796
[TBL] [Abstract][Full Text] [Related]
38. HBeAg seroconversion in children infected during early childhood with hepatitis B virus.
Roushan MR; Bijani A; Ramzaninejad S; Roushan MH; Amiri MJ; Baiani M
J Clin Virol; 2012 Sep; 55(1):30-3. PubMed ID: 22727680
[TBL] [Abstract][Full Text] [Related]
39. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.
Wong VW; Wong GL; Tsang SW; Hui AY; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
Antivir Ther; 2008; 13(4):571-9. PubMed ID: 18672536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
